Medical Mycology

Article	Citations
OUP accepted manuscript	38
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans	33
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	30
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	29
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	28
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	28
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	27
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China	26
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	26
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	24
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	24
P196 A rare presentation of subcutaneous Entomophthoramycosis	23
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	23
P361 Demystifying the NIH grant application process for international investigators	21
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	20
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	20
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	19
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	19
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories	19
S1.3c Diversity and hybridization in Malassezia furfur	19
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	18
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	18
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	17
S5.1b Antifungal r esistance	17
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	16

Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	16
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	15
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	14
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis	14
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	14
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	14
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	14
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	14
P355 Pitfalls in medical mycology in India	13
P348 tRNA modifications in Candida virulence	13
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	13
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	13
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	13
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	13
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	13
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	12
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	12
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	12
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	12
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	12
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	12
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	11
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis	11
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	11
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	11
S10.4c Successful treatment of mucormycosis in hematological diseases	11
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	11
S2.2a African histoplasmosis	11
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	10
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	10
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	10
Antifungal efficacy of natural antiseptic products against Candida auris	10
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	10
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	10
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	10
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	9
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	9
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	9
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	9
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	9
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan	9
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	9
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	9
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	9
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	9
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	9
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	9
Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel	8
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	8
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	8

P291 Aspergillosis: another force to reckon with during COVID-19 times	8
Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients	8
S9.5c Malassezia-host interactions and the Il-23/17 axis	8
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	8
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	8
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	8
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	8
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	8
P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	8
P303 An unusual case of isolated gluteal abscess	8
Opaque cell-specific proteome ofCandida albicansATCC 10231	8
Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae	8
Whole genome characterization of Trichophyton indotineae isolated in Singapore	8
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	7
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	7
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	7
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	7
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	7
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	7
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	7
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	7
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	7
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	7
Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases	7
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	7
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	7
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	7
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	7
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	7
Risk factors for COVID-19 associated mucormycosis in India: A case control study	7
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies	7
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	6
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	6
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles	6
P223 First case of Candida auris candidemia in Manipur, Northeast India	6
Biochemical characterization and analysis of gene expression of an α-mannosidase secreted by Paracoccidioides brasiliensis	6
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	6
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	6
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	6
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	6
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	6
A practical approach to investigating nosocomial acquisition of Aspergillus	6
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	6
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains	6
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	6
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	6
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	6
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	6
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	6
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	6
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	6
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	6
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	6
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus	5
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	5
Investigation of invasive fungal infection in tuberculosis/human immunodeficiency virus co-infected patients	5
Epidemiological shifts of invasive fungal infections in the current era of haematology	5
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	5
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	5
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	5
P502 Mycology lab of the future—slants to sequencing	5
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	5
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	5
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	5
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	5
A notable azole-nonsusceptible Candida orthopsilosis in the Candida parapsilosis complex isolated from onychomycosis in Hue City, Central Vietnam	5
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections	5
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	5
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	5
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	5
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	5
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	5
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	5
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	5
Value of qPCR in the screening strategy for Candida auris	5
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	5
Thanks to Reviewers	5
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	4
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	4

S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	4
Cryptococcosis in domestic and wild animals: A review	4
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	4
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	4
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	4
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	4
Identification of potential targets in bone destruction by Talaromyces marneffei: Insights from data-independent acquisition proteomics	4
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	4
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	4
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries	4
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia	4
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	4
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	4
P213 Lasiodiplodia theobromae: an emerging human pathogen	4
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems	4
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	4
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	4
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	4
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	4
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	4
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	4
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	4
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	4
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	3
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	3
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	3
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	3
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	3
Evaluation of simple molecular methods for distinction of the newly emerging dermatophyte Trichophyton indotineae	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India	3
P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method	3
Closing the Diagnostic Gap in Medical Mycology: The LODDY Test for Identification of Lodderomyces elongisporus	3
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	3
Madurella mycetomatis grains within a eumycetoma lesion are clonal	3
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	3
P075 Initial results of an international effort in screening new agents against Candida auris	3
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	3
A systematic review on distribution and antifungal resistance pattern ofCandidaspecies in the Indian population	3
A Falciformispora senegalensis grain model in Galleria mellonella larvae	3
Deciphering prognostic indicators in non-HIV cryptococcal meningitis: Constructing and validating a predictive Nomogram model	3
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis	3
Interference of Malassezia restricta in the invasion of Staphylococcus aureus into human keratinocytes	3
Octyl gallate as a treatment for Candida albicans-induced vaginal infection: Effects on fungal burden, inflammation, and Lactobacillus recovery in mice	3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	3
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study	3
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	3
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	3
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops	3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	3
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India	3
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics	3
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	3
Fungal yield from sterile specimens	3
S4.3b Candida glabrata-host interactions	3
Molecular typing and antifungal susceptibility profile of Candida krusei bloodstream isolates from Türkiye	2
Invasive mold infection of the gastrointestinal tract: A case series of 22 immunocompromised patients from a single academic center	2
Clinical characteristics and risk factors for COVID-19-associated Candidemia	2
P259 Rare presentations of Cryptococcosis: a case series	2
Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents	2
Correction to: Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List	2
P242 Autochthonous cases of Madura foot from Jodhpur, Western Rajasthan, India	2
The need for fast and accurate detection of dermatomycosis	2
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale	2
Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis	2
Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens	2
Deubiquitination module is critical for oxidative stress response and biofilm formation in Candida glabrata	2
P207 A rare case of disseminated Blastomycosis in an immunocompetent host: A report from North India	2
Comparative efficacies of the three echinocandins for Candida auris candidemia: real world evidence from a tertiary centre in India	2
Molecular identification of Fonsecaea pedrosoi in chromoblastomycosis: Insights from paraffin-embedded human skin biopsies and clinicopathology	2
Molecular epidemiology of seborrheic dermatitis/dandruff associated Malassezia species from northern India	2
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection	2
Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study	2
P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same	2
Detection of pan-azole resistant Aspergillus fumigatus in horticulture and a composting facility in Belgium	2
Detection of Blastomyces gilchristii via metagenomic sequencing in outbreak-associated soils	2
Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling	2
Detection of anti-Histoplasma capsulatum antibodies and seroconversion patterns in critically ill patients with COVID-19: An underdiagnosed fungal entity complicating COVID-19?	2
P283 A rare case of vertebral osteomyelitis caused by co-infection of Candida and Mycobacterium Tuberculosis: a double trouble	2
Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis	2
P151 Molecular epidemiology of environmental strains of Cryptococcus isolated from Varanasi, Uttar Pradesh, India	2
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis	2
High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency	2
P231 The first case of neonatal fungemia caused by Aureobasidium melanogenum	2
P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia	2